Ilya Y. Shadrin

Ilya Y. Shadrin

Auto-generated profile, based on publicly available information

Ilya Y. Shadrin

Department of Medicine Division of Cardiology Duke University Hospital Durham North Carolina USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2017 in Nature
Verified
Journal Article
Open access
PDF file
EBElad Bassat
Elad Bassat
YMYara Eid Mutlak
Yara Eid Mutlak
AGAlex Genzelinakh
Alex Genzelinakh
ISIlya Y. Shadrin
Ilya Y. Shadrin
KUKfir Baruch Umansky
Kfir Baruch Umansky
ETEldad Tzahor
Eldad Tzahor
The adult mammalian heart is non-regenerative owing to the post-mitotic nature of cardiomyocytes. The neonatal mouse heart can regenerate, but only during the first week of life. Here we show that changes in the composition of the extracellular matrix during this week can affect cardiomyocyte growth and differentiation in mice. We identify agrin, a component of neonatal extracellular matrix, as required for the full regenerative capacity of neonatal mouse hearts. In vitro, recombinant agrin promotes the division of cardiomyocytes that are derived from mouse and human induced pluripotent stem cells through a mechanism that involves the disassembly of the dystrophin–glycoprotein complex, and Yap- and ERK-mediated signalling. In vivo, a single administration of agrin promotes cardiac regeneration in adult mice after myocardial infarction, although the degree of cardiomyocyte proliferation observed in this model suggests that there are additional therapeutic mechanisms. Together, our results uncover a new inducer of mammalian heart regeneration and highlight fundamental roles of the extracellular matrix in cardiac repair.

1 July 2013 in Biomaterials
Verified
Journal Article
Closed access
DZDonghui Zhang
Donghui Zhang
ISIlya Y. Shadrin
Ilya Y. Shadrin
JLJason Lam
Jason Lam
HXHai-Qian Xian
Hai-Qian Xian
HSH. Ralph Snodgrass
H. Ralph Snodgrass
NBNenad Bursac
Nenad Bursac

13 June 2010 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
DDDaniela C Dieterich
Daniela C Dieterich
JHJennifer J L Hodas
Jennifer J L Hodas
GGGéraldine Gouzer
Géraldine Gouzer
ISIlya Y Shadrin
Ilya Y Shadrin
JNJohn T Ngo
John T Ngo
ESErin M Schuman
Erin M Schuman
Dieterich et al. describe a methodology to label all newly synthesized neuronal proteins in situ. This method, which they name FUNCAT, relies on the inclusion of noncanonical amino acids and selective fluorescent labeling via click chemistry. The authors show that this system is amenable to dual pulse-chase experiments and dynamic tracking of newly synthesized proteins. Protein translation has been implicated in different forms of synaptic plasticity, but direct in situ visualization of new proteins is limited to one or two proteins at a time. Here we describe a metabolic labeling approach based on incorporation of noncanonical amino acids into proteins followed by chemoselective fluorescence tagging by means of 'click chemistry'. After a brief incubation with azidohomoalanine or homopropargylglycine, a robust fluorescent signal was detected in somata and dendrites. Pulse-chase application of azidohomoalanine and homopropargylglycine allowed visualization of proteins synthesized in two sequential time periods. This technique can be used to detect changes in protein synthesis and to evaluate the fate of proteins synthesized in different cellular compartments. Moreover, using strain-promoted cycloaddition, we explored the dynamics of newly synthesized membrane proteins using single-particle tracking and quantum dots. The newly synthesized proteins showed a broad range of diffusive behaviors, as would be expected for a pool of labeled proteins that is heterogeneous.

28 November 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ISIlya Y. Shadrin
Ilya Y. Shadrin
BABrian W. Allen
Brian W. Allen
YQYing Qian
Ying Qian
CJChristopher P. Jackman
Christopher P. Jackman
ACAaron L. Carlson
Aaron L. Carlson
NBNenad Bursac
Nenad Bursac
Despite increased use of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) for drug development and disease modeling studies, methods to generate large, functional heart tissues for human therapy are lacking. Here we present a “Cardiopatch” platform for 3D culture and maturation of hiPSC-CMs that after 5 weeks of differentiation show robust electromechanical coupling, consistent H-zones, I-bands, and evidence for T-tubules and M-bands. Cardiopatch maturation markers and functional output increase during culture, approaching values of adult myocardium. Cardiopatches can be scaled up to clinically relevant dimensions, while preserving spatially uniform properties with high conduction velocities and contractile stresses. Within window chambers in nude mice, cardiopatches undergo vascularization by host vessels and continue to fire Ca2+ transients. When implanted onto rat hearts, cardiopatches robustly engraft, maintain pre-implantation electrical function, and do not increase the incidence of arrhythmias. These studies provide enabling technology for future use of hiPSC-CM tissues in human heart repair.

1 February 2015 in Current Opinion in Chemical Engineering
Verified
Journal Article
Closed access
CJChristopher P Jackman
Christopher P Jackman
ISIlya Y Shadrin
Ilya Y Shadrin
ACAaron L Carlson
Aaron L Carlson
NBNenad Bursac
Nenad Bursac

3 January 2023 in Mayo Clinic Proceedings
Verified
Journal Article
Open access
ISIlya Y. Shadrin
Ilya Y. Shadrin
DHDavid R. Holmes
David R. Holmes
ABAtta Behfar
Atta Behfar
The left internal mammary artery (LIMA) is considered the criterion standard vessel for use in coronary artery bypass grafting. In recent decades, countless studies have documented its superiority over other arterial and venous coronary artery bypass grafting conduits, although the full mechanisms for this superiority remain unknown. A growing body of literature has unveiled the importance of extracellular vesicles known as exosomes in cardiovascular signaling and various pathologic states. In this review, we briefly compare the clinical longevity of the LIMA relative to other conduits, explore the effects of varying grafting techniques on clinical and angiographic outcomes, and provide physiologic insights into graft function on a cellular and molecular level. Finally, we explore exosome signaling as it pertains to atherosclerosis in support of the LIMA as an "endocrine organ."